Target
Type-1 angiotensin II receptor
Ligand
BDBM50313242
Substrate
n/a
Meas. Tech.
ChEMBL_617060 (CHEMBL1100566)
Ki
0.7±n/a nM
Citation
 Fillion, DLemieux, GBasambombo, LLLavigne, PGuillemette, GLeduc, REscher, E The amino-terminus of angiotensin II contacts several ectodomains of the angiotensin II receptor AT1. J Med Chem 53:2063-75 (2010) [PubMed]  Article 
Target
Name:
Type-1 angiotensin II receptor
Synonyms:
AGTR1 | AGTR1A | AGTR1B | AGTR1_HUMAN | AT1 | AT1AR | AT1BR | AT2R1 | AT2R1B | Angiotensin II AT1 | Angiotensin II receptor | Angiotensin II type 1b (AT-1b) receptor | Type-1 angiotensin II receptor (AT1)
Type:
Protein
Mol. Mass.:
41080.75
Organism:
Homo sapiens (Human)
Description:
P30556
Residue:
359
Sequence:
MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE
  
Inhibitor
Name:
BDBM50313242
Synonyms:
CHEMBL1076603 | [Sar1,Bpa3]AngII
Type:
Small organic molecule
Emp. Form.:
C60H75N13O11
Mol. Mass.:
1154.318
SMILES:
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(cc1)C(=O)c1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O |r,wU:4.4,56.58,69.74,20.38,wD:2.2,39.49,73.77,8.17,(34.67,-36.98,;34.66,-38.57,;35.98,-39.34,;37.32,-38.56,;35.98,-40.87,;34.66,-41.63,;33.31,-40.85,;33.31,-39.33,;31.98,-41.61,;31.98,-43.17,;33.31,-43.93,;34.64,-43.18,;35.97,-43.96,;35.95,-45.5,;37.29,-46.29,;34.62,-46.26,;33.3,-45.48,;30.65,-40.84,;29.32,-41.62,;29.32,-43.17,;27.98,-40.84,;27.98,-39.31,;27.19,-37.97,;27.96,-36.62,;27.17,-35.29,;25.62,-35.3,;24.86,-36.66,;25.65,-37.99,;24.84,-33.97,;25.6,-32.63,;23.3,-33.98,;22.53,-32.66,;20.99,-32.67,;20.23,-34.01,;21.02,-35.34,;22.55,-35.32,;26.65,-41.61,;25.31,-40.84,;25.31,-39.31,;23.98,-41.61,;23.98,-43.16,;25.31,-43.92,;25.31,-45.46,;26.65,-46.23,;26.66,-47.77,;27.99,-48.53,;25.32,-48.54,;22.65,-40.82,;21.32,-41.59,;21.32,-43.14,;19.99,-40.83,;18.66,-41.59,;17.33,-40.82,;37.32,-41.64,;37.32,-43.19,;38.64,-40.88,;39.99,-41.65,;41.31,-40.89,;41.31,-39.36,;40.09,-38.45,;40.57,-36.99,;42.11,-37,;42.57,-38.47,;39.99,-43.21,;38.64,-43.98,;41.31,-43.97,;42.89,-43.43,;43.91,-44.76,;42.97,-46.14,;41.57,-45.46,;40.34,-46.39,;38.96,-45.72,;40.46,-47.92,;39.18,-48.77,;37.79,-48.1,;36.52,-48.95,;36.62,-50.49,;35.35,-51.35,;33.97,-50.68,;33.86,-49.14,;35.13,-48.28,;39.28,-50.31,;38.01,-51.17,;40.67,-50.98,)|
Structure:
Search PDB for entries with ligand similarity: